Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation

Transplantation

Volumn 66, Issue 3, 1998, Pages 334-339

  Bergan, Stein ^a,b   Rugstad, Hans E ^a   Bentdal, Øystein ^a   Sødal, Gunnar ^a   Hartmann, Anders ^a   Leivestad, Torbjørn ^a   Stokke, Oddvar ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HLA DR3 ANTIGEN;

ADULT; ARTICLE; BODY WEIGHT; BONE MARROW TOXICITY; DOSE RESPONSE; DRUG MEGADOSE; ERYTHROCYTE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032529469     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00010     Document Type: Article

References (16)

1. Opelz G. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure: the Collaborative Transplant Study. Kidney Int Suppl 1995; 52: S89.
2. Lilleyman JS, Lennard L. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet 1994; 343: 1188.
3. Bergan S, Bentdal Ø, Sødal G, Brun A, Rugstad HE, Stokke O. Patterns of azathioprine metabolites in neutrophils, lymphocytes, reticulocytes and erythrocytes: relevance to toxicity and monitoring in renal allograft recipients. Ther Drug Monit 1997; 19: 502.
4. Cuffari C, Seidman EG, Latour S, Theoret Y. Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy. Can J Physiol Pharmacol 1996; 74: 580.
5. Bergan S, Rugstad HE, Bentdal Ø, Stokke O. Monitoring of azathioprine treatment by determination of 6-thioguanine nucleotide concentrations in erythrocytes. Transplantation 1994; 58: 803.
6. Schutz E, Gummert J, Mohr FW, Armstrong VW, Oellerich M. Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine? Ther Drug Monit 1996; 18: 228.
7. Boulieu R, Lenoir A, Bertocchi M, Mornex JF. Intracellular thiopurine nucleotides and azathioprine myelotoxicity in organ transplant patients. Br J Clin Pharmacol 1997; 43: 116.
8. Bergan S, Rugstad HE, Klemetsdal B, et al. Possibilities for therapeutic drug monitoring of azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells. Ther Drug Monit 1997; 19: 318.
9. Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation - a fast and reliable technique. Tissue Antigens 1986; 28: 301.
10. Lennard L, Singleton HJ. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. J Chromatogr 1992; 583: 83.
11. Gardner MJ, Altman DG. Calculating confidence intervals for proportions and their differences. In: Gardner MJ, Altman DG, eds. Statistics with confidence. London: British Medical Journal, 1989: 28.
12. Altman DG, Gardner MJ. Calculating confidence intervals for means and their differences. In: Gardner MJ, Altman DG, eds. Statistics with confidence. London: British Medical Journal, 1989: 20.
13. Campbell MJ, Gardner MJ. Calculating confidence intervals for some non-parametric analyses. In: Gardner MJ, Altman DG, eds. Statistics with confidence. London: British Medical Journal, 1989: 71.
14. Lindholm A, Albrechtsen D, Tufveson G, Karlberg I, Persson NH, Groth CG. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation. Transplantation 1992; 54: 624.
15. Lindholm A, Albrechtsen D, Flatmark A, et al. A randomized multicenter trial of cyclosporin and prednisolone versus cyclosporin, azathioprine, and prednisolone following primary living donor renal transplantation. Transplant Int 1994; 7: 207.
16. Sandborn WJ, Van O EC, Zins BJ, Tremaine WJ, Mays DC, Lipsky JJ. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease. Gastroenterology 1995; 109: 1808.